Loading...

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile

BACKGROUND: The newly developed Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) has consistently been shown to be prognostically significant in endometrial carcinomas (EC). Recently, we and others have demonstrated L1 cell-adhesion molecule (L1CAM) to be a significant indicator...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Cancer
Main Authors: Kommoss, Felix KF, Karnezis, Anthony N., Kommoss, Friedrich, Talhouk, Aline, Taran, Florin-Andrei, Staebler, Annette, Gilks, C. Blake, Huntsman, David G., Krämer, Bernhard, Brucker, Sara Y., McAlpine, Jessica N., Kommoss, Stefan
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group UK 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134076/
https://ncbi.nlm.nih.gov/pubmed/30050154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0187-6
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!